We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Follow

GQ Life Sciences Blog Blog

Articles: 1-10 of 12

Searching for variant sequences with pinpoint accuracy

USA - August 2 2018 The global market for bioengineered protein drugs is expected to reach $228.4 billion by 2021, up from $172.5 billion in 2016, rising at a compound…

Patent Sequence Search: You’re Doing It Wrong

USA - September 9 2016 After 15 years in this field and writing about this many times, I’m still shocked when I see professional IP people that use BLAST for their sequence…

Why Successful Research Begins with Better Patent Searching (Part 2)

USA - August 9 2016 Mechanical, chemical, and life sciences patents in particular, pose their own challenges to searching. In all of these Technologies, inventions can…

Why Successful Research Begins with Better Patent Searching (Part 1)

European Union, USA - August 4 2016 In every stage of innovation, knowledge of current and previous research is critical to developing a clear direction to progress forward. From…

Patentability of Genetic Material - Australian Rules

Australia, USA - May 25 2016 After the United States Supreme Court ruling in the Association for Molecular Pathology v. Myriad Genetics in June of 2013, the industry scurried…

Copyright Protection of DNA Sequences: Market Implications (Part 2)

USA - May 10 2016 The first installment of this two-part series on copyright sequence searching focused on the Copyright Office’s use of search in conjunction with…

Unlocking DNA Copyright Protection with Sequence Searches (Part 1)

USA - May 2 2016 If copyright protection becomes available for a significant number of engineered genetic sequences, copyright sequence searching could become just as…

Challenges and Opportunities for Biosimilar Drugs on the US Market

USA - April 5 2016 About a week ago, the FTC filed a suit against Endo Pharmaceuticals (among others) for blocking generic competition of its Opana ER and Lidoderm…

How the Acceleration of Innovation is Impacting IP Strategy: The Ever Faster Pace of Innovation

USA - March 31 2016 It's hard not to notice that the future is arriving faster than ever. Innovations are arriving at breakneck speed. In just the last couple of years…

Copyright for Engineered DNA (Part 3)

USA - March 8 2016 With the United States Supreme Court ruling in Myriad, the enforceability of certain claims in existing gene patents and the broader patentability of…